economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Governments

Sanjay Malhotra’s appointment as RBI governor reflects government’s faith in IAS officers, says expert Sanjay-Malhotra.jpg

Sanjay Malhotra’s appointment as RBI governor reflects government’s faith in IAS officers, says expert

creativebharatgroup@gmail.com December 9, 2024
Sanjay Malhotra, a 1990-batch IAS officer from the Rajasthan cadre, has been appointed as the 26th Governor...
Read More Read more about Sanjay Malhotra’s appointment as RBI governor reflects government’s faith in IAS officers, says expert
CS MEDICA Welcomes the Danish Government’s Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent

CS MEDICA Welcomes the Danish Government’s Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent

creativebharatgroup@gmail.com November 22, 2024
Permanent regulation could pave the way for better access and understanding of CBD’s...
Read More Read more about CS MEDICA Welcomes the Danish Government’s Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen OG_Companylog_92449.jpg

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

creativebharatgroup@gmail.com November 14, 2024
MUMBAI, India & HYDERABAD, India:  PopVax, an Indian full-stack biotechnology company developing novel...
Read More Read more about PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen